Leap Therapeutics Inc share price logo

Leap Therapeutics Inc Share Price

NASDAQ: LPTX

$2.04

+1.61

(+367.43%)

Live

as on

Bell Icon

The stock has been delisted from the stock exchange on 12 Nov 2025

Leap Therapeutics Inc Stock Performance

as on November 13, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $0.58
    $2.54
    downward going graph

    71.57%

    Downside

    24.51%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.22
    $3.58
    downward going graph

    89.10%

    Downside

    75.49%

    Upside

    downward going graph

Leap Therapeutics Inc share price movements today

Previous Close
$0.44
Open
$0.61
Volume
1.2B
Day's Low - High
$0.58 - $2.54
52 Week Low - High
$0.22 - $3.58

Leap Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Leap Therapeutics Inc Stock Fundamentals & Key Indicators

Check Leap Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Leap Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Leap Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%
BUY$44.1B436.37%-16.34-264.83%
BUY$57.7B246.14%1407.681.36%
BUY$109.4B94.41%30.0331.35%
BUY$80.1B49.8%18.1132.13%

Analyst Recommendation on Leap Therapeutics Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Leap Therapeutics Inc. Average target price of $3

Leap Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Leap Therapeutics Inc.

What analysts predicted

32%UPSIDE

Target Price

$3

Current Price

$2.04

Analyzed by

10 Analysts

Target

$3.00

Leap Therapeutics Inc target price $3, a slight upside of 32% compared to current price of $2.04. According to 10 analysts rating.

Leap Therapeutics Inc Stock’s Investor Sentiment and Interest

Investment in Leap Therapeutics Inc Shares on INDmoney has grown by 94.44% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:94.44% versus previous 30 day period

Leap Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
0
-
-
-
0
-
-
Gross Profit
0
0
0
0
0
-
-
0
-
-
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-41
-13
-13
-12
-13
-20
-18
-15
-15
-16
Net Profit Margin
0.00%
0.00%
0.00%
-1966.09%
0.00%
0.00%
0.00%
-154310.00%
0.00%
0.00%

Leap Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
0
1
1
0
-
-
Gross Profit
-
0
0
0
0
1
1
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-21
-25
-29
-23
-32
-27
-40
-54
-81
-67
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-8773.33%
-1834.27%
-2705.80%
-14558.93%
0.00%
0.00%

Global Institutional Holdings in Leap Therapeutics Inc

Funds
Holdings
683 Capital Management LLC
3.48%
Vanguard Group Inc
2.8%
HighTower Advisors, LLC
2.65%
Monaco Asset Management
2.53%
Simplify Asset Management Inc.
2.07%

Leap Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 13 November

    Thu, 02:16 PM

    -

    Leap Therapeutics announces significant corporate changes, including rebranding to Cypherpunk Technologies and a digital asset treasury strategy.

    Thu, 08:32 PM

    -

    Leap Therapeutics stock surged 368% after announcing digital asset investments and rebranding, but fell 25% in pre-market trading.

Insights on Leap Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LPTX stock has moved up by 347.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 924.7% return, outperforming this stock by 995.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 172.8% return, outperforming this stock by 201.9%

About Leap Therapeutics Inc

Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways. The Company’s lead clinical stage drug candidate is sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1 (DKK1). DKK1 is also a modulator of CKAP4/PI3K/AKT signaling. The Company is developing DKN-01 in a clinical trial in patients with colorectal cancer and has also conducted clinical trials in patients with gastric/gastroesophageal junction cancer and endometrial cancer patients. The Company also has a preclinical program to develop a proprietary monoclonal antibody known as FL-501. FL-501 is a monoclonal antibody in preclinical development that targets growth and differentiation factor 15 (GDF15), which is a cytokine that is produced at elevated levels in response to various stresses.
OrganisationLeap Therapeutics Inc
E-voting on sharesClick here to vote

FAQs

What is Leap Therapeutics Inc share price today?

Leap Therapeutics Inc share price today is $2.04 as on . Leap Therapeutics Inc share today touched a day high of $2.54 and a low of $0.58.

What is the 52 week high and 52 week low for Leap Therapeutics Inc share?

Leap Therapeutics Inc share touched a 52 week high of $3.58 on and a 52 week low of $0.22 on . Leap Therapeutics Inc stock price today i.e. is trending at $2.04,which is 43.02% down from its 52 week high and 817.68% up from its 52 week low.

How to invest in Leap Therapeutics Inc Stock (LPTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Leap Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Leap Therapeutics Inc Shares that will get you 0.7353 shares as per Leap Therapeutics Inc share price of $2.04 per share as on November 13, 2025 at 2:29 am IST.

What is the minimum amount required to buy Leap Therapeutics Inc Stock (LPTX) from India?

Indian investors can start investing in Leap Therapeutics Inc (LPTX) shares with as little as ₹89.162 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹891.62 in Leap Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Leap Therapeutics Inc share’s latest price of $2.04 as on November 13, 2025 at 2:29 am IST, you will get 4.9020 shares of Leap Therapeutics Inc. Learn more about fractional shares .